Logo-jnp
J Nephropathol. 2019;8(3): e26. doi: 10.15171/jnp.2019.26

Original Article

Urinary podocin level as a predictor of diabetic kidney disease

Abdelbassit ElShaarawy 1 ORCID, Maha Abdelmoneim Behairy 1 * , Somia Abdelhameed Bawady 2, Hoda Ahmed Abdelsattar 2 * , Eman Shadad 3

Cited by CrossRef: 5

1- Karatoy Erdem B, Özcan M, Yılmaz V, Akkaya B, Çetinkaya R, Ersoy F, Süleymanlar G, Akbas H. A UFLC-MS/MS Method for the Simultaneous Analysis of Urinary Podocin and Podocalyxin in Patients with Nephrotic Syndrome. 2022;53(3):246 [Crossref]
2- Nugroho P, Saragih R, Lydia A, Muhadi M, Isbagio H, Shatri H, Chundiawan C, Hermanto F. Correlation of Asymmetric Dimethylarginine With Podocytopathy Markers in Diabetic Kidney Disease Patients. IJNRD. 2024;Volume 17:255 [Crossref]
3- Mizdrak M, Kumrić M, Kurir T, Božić J. Emerging Biomarkers for Early Detection of Chronic Kidney Disease. JPM. 2022;12(4):548 [Crossref]
4- Mohani C, Rudijanto A, Aulanni’am A, Soeharto S. DLBS3233 enhances nephrin and podocin expression also reduces oxidative stress marker and insulin receptor serine diabetic rats’ podocytes. 2023;85(8):3894 [Crossref]
5- Jana S, Mitra P, Roy S. Proficient Novel Biomarkers Guide Early Detection of Acute Kidney Injury: A Review. Diseases. 2022;11(1):8 [Crossref]
6- Zhu X, Zhang C, Liu L, Xu L, Yao L. Senolytic combination of dasatinib and quercetin protects against diabetic kidney disease by activating autophagy to alleviate podocyte dedifferentiation via the Notch pathway. Int J Mol Med. 2024;53(3) [Crossref]